查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1736526

全球猪瘟疫苗市场规模（依产品、应用、区域范围及预测）

Global Swine Fever Vaccine Market Size By Product, By Application, By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 | 商品交期: 2-3个工作天内

价格
简介目录

猪瘟疫苗市场规模及预测

2024 年猪瘟疫苗市场规模为 16 亿美元，预计到 2032 年将达到 26 亿美元，2026 年至 2032 年的复合年增长率为 5.1%。

推动全球猪瘟疫苗市场的因素

猪瘟疫苗市场的市场驱动因素可能受到多种因素的影响，其中包括：

生猪数量不断增加：随着全球生猪数量持续增长，尤其是在亚洲和拉丁美洲等地区，对有效疫苗预防猪瘟等疾病的需求也日益增加。

政府措施与法规：为了控制和遏制猪流感疫情，政府和监管机构经常强制推行疫苗接种计画。猪流感疫苗市场受立法和政策驱动。

对疾病爆发的担忧日益加剧：猪瘟爆发可能对养猪业带来重大经济损失。这些传染病的重要性正日益得到农民和其他相关人员的广泛认可，推动了对疫苗接种作为预防策略的需求。

技术发展：开发更安全、更有效的免疫接种是技术进步的一个方面，有助于疫苗产业扩大市场。这包括佐剂技术、疫苗配方和递送技术的进步。

加强教育和意识：市场需求的驱动力源自于养猪户对疫苗接种和疾病预防价值的认知不断加深。进行宣传教育宣传活动，强调疫苗接种在疾病防治中的作用至关重要。

养猪业全球化：养猪业跨国家和地区互联互通，因此疾病爆发可能造成重大影响。强而有力的疫苗接种计画至关重要，而全球化这一因素正在帮助扩大市场。

研发投入：生技和製药公司的研发投入将推动新型、更优的猪瘟疫苗的开发。这些发展将推动竞争和商业性扩张。

重视动物健康和福利：畜牧业更重视动物健康和福利标准，鼓励接种疫苗以预防猪瘟等疾病，有助于扩大市场。

限制全球猪瘟疫苗市场的因素

猪瘟疫苗市场可能面临多种限制与挑战，包括：

监管挑战：由于严格的安全标准和法规，获得猪瘟疫苗的核准成本高且耗时。这项流程可能会延迟新产品的上市，并为新的竞争对手设定进入障碍。

知识和教育有限：在某些地区，农民和牲畜饲养者可能尚未充分认识到猪瘟疫苗的益处。这可能导致疫苗接种覆盖率低和需求减少，尤其是在猪流感发病率较低的地区。

疫苗接种计画成本高昂：在大型猪群参与综合疫苗接种计画时，农民和政府可能会承担巨额成本。疫苗的采购、管理和安排接种费用可能是一个重大障碍，尤其对于资源匮乏地区的小型农场而言。

物流挑战：维护疫苗储存和分发的低温运输是高效率向偏远农村地区分发疫苗的物流挑战之一。此类行政障碍可能会限制所有养猪户获得疫苗，这可能会影响市场渗透率。

有效性和安全性问题：对于製造商而言，猪流感疫苗的有效性和安全性至关重要。疫苗对不同病毒株的有效性、可能的副作用以及长期免疫力等问题会影响生产者对疫苗接种计划的信心和采用。

竞争激烈的市场环境：价格竞争和产品差异化是市场上存在多家疫苗生产商和产品可能带来的竞争压力的两个例子。竞争格局可能会限制个别疫苗供应商的扩张，并影响市场的整体动态。

贸易壁垒和出口问题：猪瘟疫情可能会限制来自疫区的猪产品的贸易，这可能会间接影响对猪瘟疫苗的需求，因为生产商对市场进入和出口潜力持怀疑态度，并且不愿意投资疫苗接种计划。

目录

第一章 猪瘟疫苗全球市场介绍

  • 市场定义
  • 市场区隔
  • 调查时间表
  • 先决条件
  • 限制

第 2 章 已验证的市场研究调查方法

  • 资料探勘
  • 数据三角测量
  • 自下而上的方法
  • 自上而下的方法
  • 调查流程
  • 业界专家的重要见解
  • 资料来源

第三章执行摘要

  • 市场概览
  • 生态测绘
  • 绝对的商机
  • 市场吸引力
  • 全球猪瘟疫苗市场区域分析
  • 全球猪瘟疫苗市场（按产品划分）（百万美元）
  • 全球猪瘟疫苗市场应用（百万美元）
  • 未来市场机会
  • 世界市场结构
  • 产品生命线

第四章 全球猪瘟疫苗市场展望

  • 猪瘟疫苗的全球演变
  • 驱动程式
    • 司机1
    • 司机2
  • 限制因素
    • 约束因素 1
    • 约束因素 2
  • 机会
    • 机会1
    • 机会2
  • 波特五力模型
  • 价值链分析
  • 定价分析
  • 宏观经济分析

第五章全球猪瘟疫苗市场（依产品）

  • 概述
  • 组织培养衍生
  • 细胞株来源

6. 全球猪瘟疫苗市场（依应用）

  • 概述
  • 政府竞标
  • 市场销售

7. 全球猪瘟疫苗市场（按地区）

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲
  • 中东和非洲
    • 阿拉伯聯合大公国
    • 沙乌地阿拉伯
    • 南非
    • 其他中东和非洲地区

第八章全球猪瘟疫苗市场竞争格局

  • 概述
  • 各公司市场排名
  • 公司地理分布
  • 公司产业布局
  • ACE矩阵

第九章 公司简介

  • Ceva
  • Boehringer Ingelheim International
  • Bioveta
  • Panav BIoTech
  • WINSUN
  • Merial
  • CAHIC
  • Chopper Biology
  • MSD Animal Health
  • ChengDu Tecbond

第十章 已验证的市场情报

  • 关于已验证的市场情报
  • 动态资料视觉化
简介目录
Product Code: 37468

Swine Fever Vaccine Market Size And Forecast

Swine Fever Vaccine Market size was valued at USD 1.6 Billion in 2024 and is projected to reach USD 2.6 Billion by 2032, growing at a CAGR of 5.1% during the forecast period 2026-2032.

Global Swine Fever Vaccine Market Drivers

The market drivers for the Swine Fever Vaccine Market can be influenced by various factors. These may include:

Growing Swine Population: There is an increasing need for efficient vaccines to prevent diseases like swine fever as the world's pig population continues to grow, particularly in areas like Asia and Latin America.

Government Initiatives and Regulations: To manage and stop swine flu outbreaks, governments and regulatory agencies frequently require vaccination programmes. The market for swine flu vaccinations is driven by laws and policies that are supportive.

Growing Fears Regarding Disease Outbreaks: The swine sector may suffer large financial losses as a result of swine fever outbreaks. The significance of these epidemics is becoming more widely recognised among farmers and other stakeholders, which is driving up demand for vaccinations as a preventive strategy.

Technological developments: The creation of safer and more effective vaccinations is one aspect of the vaccine industry's technological advancements that support market expansion. This covers developments in adjuvant technology, vaccination formulation, and delivery techniques.

Growing Education and Awareness: Market demand is driven by swine farmers' growing understanding of the value of immunisation and illness prevention. Campaigns for education that emphasise the advantages of vaccinations for the prevention and control of disease are important.

Globalisation of the Swine Industry: Disease outbreaks can have a significant impact due to the interconnectedness of the swine industry across nations and regions. Strong immunisation programmes are required, and this globalisation element propels market expansion.

Research and Development Investments: New and better swine fever vaccines are developed as a result of research and development investments made by biotech and pharmaceutical companies. Competitiveness and commercial expansion are fueled by these developments.

Focus on Animal Health and Welfare: As the livestock business places a greater emphasis on animal health and welfare standards, vaccination use to ward off diseases like swine fever is encouraged, which propels market expansion.

Global Swine Fever Vaccine Market Restraints

Several factors can act as restraints or challenges for the Swine Fever Vaccine Market . These may include:

Regulatory Challenges: Due to strict safety standards and regulatory regulations, obtaining regulatory approval for swine fever vaccines can be costly and time-consuming. This procedure may delay the release of new products and serve as a barrier to entry for new competitors.

Limited Knowledge and Education: In certain areas, farmers and livestock owners might not be fully informed of the advantages of swine fever vaccine. This may result in slower adoption rates and decreased demand for vaccinations, especially in regions with fewer swine flu outbreaks.

High Expense of Vaccination Programmes: Farmers and governments may incur significant expenses when putting big swine populations through comprehensive vaccination programmes. Vaccine procurement, administration, and schedule management costs can be a major barrier, particularly for small-scale farms in areas with scarce resources.

Logistical Difficulties: Maintaining the cold chain for vaccine storage and delivery is one logistical problem in the efficient distribution of vaccinations to remote or rural locations. These administrative obstacles may limit vaccination accessibility for all swine farmers, which may have an effect on market penetration.

Efficacy and Safety Concerns: For manufacturers, the effectiveness and safety of swine flu vaccinations are paramount. The effectiveness of vaccines against various virus strains, possible side effects, and long-term immunity are some of the issues that can affect producer trust in vaccination programmes and adoption rates.

Competitive Market Environment: Price wars and product differentiation are two examples of the competitive pressures that can arise from the existence of several vaccine producers and products on the market. The competitive landscape could limit the expansion of individual vaccine suppliers and affect the general dynamics of the market.

Trade Barriers and Export Issues: Outbreaks of swine fever may result in trade restrictions on pig products originating from impacted areas. Because producers would be hesitant to invest in immunisation programmes due to doubts about market access and export potential, this could have an indirect effect on the demand for swine fever vaccinations.

Global Swine Fever Vaccine Market Segmentation Analysis

The Global Swine Fever Vaccine Market is segmented on the basis of Product, Application, and Geography.

Swine Fever Vaccine Market, By Product

  • Tissue Culture Origin
  • Cell Line Origin

Based on Product, The market is segmented into Tissue Culture Origin and Cell Line Origin. The Tissue Culture Origin segment is anticipated to dominate the Global Swine Fever Vaccine Market. The US biopharmaceutical industries heavily rely on cell culture for tissue culture, drug research, and vaccine manufacture. The segment is expected to develop significantly since tissue culture is vital in the traditional Swine Fever Vaccine.

Swine Fever Vaccine Market, By Application

  • Government Tender
  • Market Sales

Based on Application, The market is segmented into Government Tender and Market Sales. The Government Tender segment is anticipated to dominate the Global Swine Fever Vaccine Market. Due to the government's intense attention on preventing the spread of classical swine disease, a government tender for the sale of the vaccine is set.

Swine Fever Vaccine Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world
  • On the basis of Geography, the Global Swine Fever Vaccine Market is classified into North America, Europe, Asia Pacific, And Rest of the world. North America will hold the largest Global Swine Fever Vaccine Market. The US supplied the largest market share in the North American market for classical Swine Fever Vaccines throughout the forecast period. The region's market for traditional Swine Fever Vaccines is expanding due to several factors, including the region's highly developed healthcare system and the significant investment in R&D to create innovative vaccines for various illnesses.

Key Players

  • The major players in the Swine Fever Vaccine Market are:
  • WINSUN
  • Merial
  • CAHIC
  • Chopper Biology
  • MSD Animal Health
  • ChengDu Tecbond
  • Ceva
  • Veterinary
  • Ringpu Biology
  • Jinyu Bio-Technology
  • Institute Pasteur
  • TecOn
  • Panav Biotech
  • Boehringer Ingelheim International

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL SWINE FEVER VACCINE MARKET

  • 1.1 Market Definition
  • 1.2 Market Segmentation
  • 1.3 Research Timelines
  • 1.4 Assumptions
  • 1.5 Limitations

2 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 2.1 Data Mining
  • 2.2 Data Triangulation
  • 2.3 Bottom-Up Approach
  • 2.4 Top-Down Approach
  • 2.5 Research Flow
  • 2.6 Key Insights from Industry Experts
  • 2.7 Data Sources

3 EXECUTIVE SUMMARY

  • 3.1 Market Overview
  • 3.2 Ecology Mapping
  • 3.3 Absolute Market Opportunity
  • 3.4 Market Attractiveness
  • 3.5 Global Swine Fever Vaccine Market Geographical Analysis (CAGR %)
  • 3.6 Global Swine Fever Vaccine Market, By Product (USD Million)
  • 3.7 Global Swine Fever Vaccine Market, By Application (USD Million)
  • 3.8 Future Market Opportunities
  • 3.9 Global Market Split
  • 3.10 Product Life Line

4 GLOBAL SWINE FEVER VACCINE MARKET OUTLOOK

  • 4.1 Global Swine Fever Vaccine Evolution
  • 4.2 Drivers
    • 4.2.1 Driver1
    • 4.2.2 Driver 2
  • 4.3 Restraints
    • 4.3.1 Restraint1
    • 4.3.2 Restraint 2
  • 4.4 Opportunities
    • 4.4.1 Opportunity1
    • 4.4.2 Opportunity 2
  • 4.5 Porters Five Force Model
  • 4.6 Value Chain Analysis
  • 4.7 Pricing Analysis
  • 4.8 Macroeconomic Analysis

5 GLOBAL SWINE FEVER VACCINE MARKET, BY PRODUCT

  • 5.1 Overview
  • 5.2 Tissue Culture Origin
  • 5.3 Cell Line Origin

6 GLOBAL SWINE FEVER VACCINE MARKET, BY APPLICATION

  • 6.1 Overview
  • 6.2 Government Tender
  • 6.3 Market Sales

7 GLOBAL SWINE FEVER VACCINE MARKET, BY GEOGRAPHY

  • 7.1 Overview
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 U.K.
    • 7.3.3 France
    • 7.3.4 Italy
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Rest of Asia Pacific
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Argentina
    • 7.5.3 Rest of Latin America
  • 7.6 Middle-East and Africa
    • 7.6.1 UAE
    • 7.6.2 Saudi Arabia
    • 7.6.3 South Africa
    • 7.6.4 Rest of Middle-East and Africa

8 GLOBAL SWINE FEVER VACCINE MARKET COMPETITIVE LANDSCAPE

  • 8.1 Overview
  • 8.2 Company Market Ranking
  • 8.3 Key Developments
  • 8.4 Company Regional Footprint
  • 8.5 Company Industry Footprint
  • 8.6 ACE Matrix

9 COMPANY PROFILES

  • 9.1 Ceva
    • 9.1.1 Company Overview
    • 9.1.2 Company Insights
    • 9.1.3 Product Benchmarking
    • 9.1.4 Key Developments
    • 9.1.5 Winning Imperatives
    • 9.1.6 Current Focus & Strategies
    • 9.1.7 Threat from Competition
    • 9.1.8 SWOT Analysis
  • 9.2 Boehringer Ingelheim International
    • 9.2.1 Company Overview
    • 9.2.2 Company Insights
    • 9.2.3 Product Benchmarking
    • 9.2.4 Key Developments
    • 9.2.5 Winning Imperatives
    • 9.2.6 Current Focus & Strategies
    • 9.2.7 Threat from Competition
    • 9.2.8 SWOT Analysis
  • 9.3 Bioveta
    • 9.3.1 Company Overview
    • 9.3.2 Company Insights
    • 9.3.3 Product Benchmarking
    • 9.3.4 Key Developments
    • 9.3.5 Winning Imperatives
    • 9.3.6 Current Focus & Strategies
    • 9.3.7 Threat from Competition
    • 9.3.8 SWOT Analysis
  • 9.4 Panav Biotech
    • 9.4.1 Company Overview
    • 9.4.2 Company Insights
    • 9.4.3 Product Benchmarking
    • 9.4.4 Key Developments
    • 9.4.5 Winning Imperatives
    • 9.4.6 Current Focus & Strategies
    • 9.4.7 Threat from Competition
    • 9.4.8 SWOT Analysis
  • 9.5 WINSUN
    • 9.5.1 Company Overview
    • 9.5.2 Company Insights
    • 9.5.3 Product Benchmarking
    • 9.5.4 Key Developments
    • 9.5.5 Winning Imperatives
    • 9.5.6 Current Focus & Strategies
    • 9.5.7 Threat from Competition
    • 9.5.8 SWOT Analysis
  • 9.6 Merial
    • 9.6.1 Company Overview
    • 9.6.2 Company Insights
    • 9.6.3 Product Benchmarking
    • 9.6.4 Key Developments
    • 9.6.5 Winning Imperatives
    • 9.6.6 Current Focus & Strategies
    • 9.6.7 Threat from Competition
    • 9.6.8 SWOT Analysis
  • 9.7 CAHIC
    • 9.7.1 Company Overview
    • 9.7.2 Company Insights
    • 9.7.3 Product Benchmarking
    • 9.7.4 Key Developments
    • 9.7.5 Winning Imperatives
    • 9.7.6 Current Focus & Strategies
    • 9.7.7 Threat from Competition
    • 9.7.8 SWOT Analysis
  • 9.8 Chopper Biology
    • 9.8.1 Company Overview
    • 9.8.2 Company Insights
    • 9.8.3 Product Benchmarking
    • 9.8.4 Key Developments
    • 9.8.5 Winning Imperatives
    • 9.8.6 Current Focus & Strategies
    • 9.8.7 Threat from Competition
    • 9.8.8 SWOT Analysis
  • 9.9 MSD Animal Health
    • 9.9.1 Company Overview
    • 9.9.2 Company Insights
    • 9.9.3 Product Benchmarking
    • 9.9.4 Key Developments
    • 9.9.5 Winning Imperatives
    • 9.9.6 Current Focus & Strategies
    • 9.9.7 Threat from Competition
    • 9.9.8 SWOT Analysis
  • 9.10 ChengDu Tecbond
    • 9.10.1 Company Overview
    • 9.10.2 Company Insights
    • 9.10.3 Product Benchmarking
    • 9.10.4 Key Developments
    • 9.10.5 Winning Imperatives
    • 9.10.6 Current Focus & Strategies
    • 9.10.7 Threat from Competition
    • 9.10.8 SWOT Analysis

10. VERIFIED MARKET INTELLIGENCE

  • 10.1 About Verified Market Intelligence
  • 10.2 Dynamic Data Visualization